Analysts expect Sutro Biopharma, Inc. to report revenue of 14.54 M for Q3 26, against a range of 13.38 M to 15.70 M. The most recent reported quarter, Q2 26, came in at 9.84 M, a 13.0% miss against the 11.32 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 8.52 M | 14.80 M | 17.40 M | 63.74 M | 9.69 M | 11.65 M | 14.52 M | 9.84 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 15.49 M | 13.23 M | 11.61 M | 16.02 M | 10.54 M | 10.66 M | 10.30 M | 12.07 M | 15.70 M | 13.68 M | 8.96 M | 8.76 M | 10.16 M | 11.54 M | 8.40 M | 9.67 M | ||||||||||
| Low Estimate | 14.37 M | 12.21 M | 10.47 M | 14.01 M | 9.20 M | 8.87 M | 8.68 M | 10.56 M | 13.38 M | 12.50 M | 7.36 M | 7.28 M | 8.77 M | 10.32 M | 7.79 M | 8.99 M | ||||||||||
| Consensus Estimate | 14.93 M | 12.72 M | 11.04 M | 15.02 M | 9.87 M | 9.77 M | 9.49 M | 11.32 M | 14.54 M | 13.09 M | 8.16 M | 8.02 M | 9.47 M | 10.93 M | 8.09 M | 9.33 M |
Analysts expect Sutro Biopharma, Inc. to report earnings per share of -1.71 for Q3 26, against a range of -1.86 to -1.56. The most recent reported quarter, Q2 26, came in at -2.33, a 3.1% miss against the -2.26 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -5.90 | -8.30 | -9.10 | -1.40 | -6.70 | -5.29 | -2.94 | -2.33 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -7.27 | -7.63 | -5.45 | -3.44 | -3.47 | -8.14 | -2.47 | -2.10 | -1.56 | -1.54 | -1.98 | -1.71 | -2.00 | -0.89 | -1.36 | -0.82 | ||||||||||
| Low Estimate | -8.05 | -8.23 | -6.53 | -3.76 | -3.97 | -8.74 | -2.69 | -2.42 | -1.86 | -1.68 | -2.24 | -1.99 | -2.22 | -1.03 | -1.52 | -0.92 | ||||||||||
| Consensus Estimate | -7.66 | -7.93 | -5.99 | -3.60 | -3.72 | -8.44 | -2.58 | -2.26 | -1.71 | -1.61 | -2.11 | -1.85 | -2.11 | -0.96 | -1.44 | -0.87 |
Pull Wall Street consensus for Sutro Biopharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=STRO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "STRO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=STRO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();